David Kinsley Selected Research

SCH 546738

1/2012

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Kinsley Research Topics

Disease

3	Inflammation (Inflammations) 03/2011 - 09/2009
1	Tauopathies 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Experimental Arthritis 01/2012
1	Rheumatoid Arthritis 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Multiple Sclerosis 01/2012
1	Non-alcoholic Fatty Liver Disease 03/2011
1	Body Weight (Weight, Body) 03/2011
1	Fatty Liver 03/2011
1	Hyperinsulinism (Hyperinsulinemia) 03/2011
1	Obesity 01/2010
1	Hypersensitivity (Allergy) 09/2009

Drug/Important Bio-Agent (IBA)

1	hexosaminidase CIBA 01/2020
1	tau Proteins (tau Protein)IBA 01/2020
1	CXCR3 ReceptorsIBA 01/2012
1	SCH 546738IBA 01/2012
1	Alanine Transaminase (SGPT)IBA 03/2011
1	EnzymesIBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	Rosiglitazone (Avandia)FDA Link 01/2010
1	CholesterolIBA 01/2010
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 09/2009
1	AntigensIBA 09/2009
1	Immunomodulating AgentsIBA 09/2009
1	doramapimodIBA 09/2009
1	Immunologic Factors (Immunomodulators)IBA 09/2009
1	Phosphotransferases (Kinase)IBA 09/2009

Therapy/Procedure

1	Therapeutics 01/2012
1	Heart Transplantation (Grafting, Heart) 01/2012